# Major Recall Alert: APO-CANDESARTAN TABLETS Recalled Due to Noncompliant Active Ingredient Dissolution
Canadian pharmaceutical company, Apotex Inc., has issued a serious recall for certain lots of its **APO-CANDESARTAN Tablets**. This recall was initiated because the affected lots were manufactured using an active ingredient that was found to be out of specification for dissolution. If you or someone you know uses this product, it’s important to take immediate precautions. Here’s everything you need to know about this crucial health alert.
## Why This Recall is Important
The issue stems from the use of an **active ingredient that did not meet dissolution specifications** during manufacturing. Dissolution measures how quickly a drug breaks down and becomes available for absorption into the body. An out-of-specification dissolution could result in the product not working as intended, potentially impacting its efficacy in managing conditions like high blood pressure and heart failure.
APO-CANDESARTAN Tablets are commonly prescribed to lower blood pressure and protect the cardiovascular system, making safety and consistency critical for patients relying on this medication. If these tablets fail to dissolve as required, there’s a risk they won’t deliver the intended therapeutic benefits, posing a danger to those with existing health conditions.
## Details of the Recall
Here are the key details surrounding the recall of APO-CANDESARTAN Tablets:
- **Brand:** Apotex Inc.
- **Product Name:** APO-CANDESARTAN Tablets
- **Issue:** Active ingredient was out of specification for dissolution
- **Category:** Medication (CAN)
- **Date Announced:** October 31, 2023
- **Reason for Recall:** Manufacturing issue with the active ingredient, leading to dissolution discrepancies.
For further details, including a list of affected lot numbers, please refer to the [official recall notice](https://recalls-rappels.canada.ca/en/alert-recall/apo-candesartan-affected-lots-were-manufactured-using-active-ingredient-was-out).
## What You Should Do
If you are currently taking APO-CANDESARTAN Tablets, follow these steps to ensure your safety:
- **Check Your Lot Number:** Compare the lot number on your prescription bottle or packaging with the list of recalled lot numbers in the official notice linked above.
- **Contact Your Healthcare Provider:** Speak with your doctor or pharmacist for guidance on alternative medications or further steps to manage your condition.
- **Stop Use (If Applicable):** If your medication matches the affected lots, discontinue use immediately but continue consulting your healthcare provider as stopping medication suddenly may pose risks.
- **Report Adverse Effects:** If you have experienced any adverse reactions or side effects, report them to **Health Canada** or your local medical authority as soon as possible.
Your health and safety are of utmost importance. Taking quick action can mitigate any potential risks associated with this recall.
## Stay Safe – Get Instant Recall Alerts
Recalls like this highlight the importance of staying informed about potential risks to your health. To stay updated on critical safety announcements, we recommend downloading our **Recalls App** today. With instant notifications, product scans, and up-to-date information, you’ll never miss an important alert again.
🔽 **[Download the Recalls App Now](#)** for free and ensure you’re always prepared!
Take control of your health and safety with the latest updates on product recalls that matter most.
---
For additional information, visit the **official recall notice** from Health Canada:
👉 [Health Canada Recall Notice: APO-CANDESARTAN Tablets](https://recalls-rappels.canada.ca/en/alert-recall/apo-candesartan-affected-lots-were-manufactured-using-active-ingredient-was-out)
By staying informed and acting promptly, you can protect yourself and your loved ones from unnecessary health risks.